Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Regulatory News (AGY)

Share Price Information for Allergy Thera. (AGY)

Share Price is delayed by 15 minutes
Get Live Data
8.50    0.36 (4.24%)
Bid:
8.00
Ask:
9.00
Spread: 1.00 (12.50%)
Market Cap: £561.06m
AGY Live PriceLast checked at - London Stock Exchange

Intraday Allergy Thera. Share Chart

BLOCK LISTING SIX MONTHLY RETURN

16 Jul 2018 08:53

RNS Number : 7205U
Allergy Therapeutics PLC
16 July 2018
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 11 JULY 2018

 

Name of applicant:

ALLERGY THERAPEUTICS PLC

Name of scheme:

Allergy Therapeutics plc 2013 Long Term Incentive Plan

Period of return:

From:

21 Nov 2017

To:

11 July 2018

Balance of unallotted securities under scheme(s) from previous return:

10,000,000

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

 2,050,848

 

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

 7,949,152

 

 

Name of contact:

Sara Goldsbrough

Telephone number of contact:

+44 (0) 7966 165719 

 

 

Total Voting Rights

 

The total number of voting rights of the company is 596,168,616. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify an interest in, or a change to their interest in, the share capital of the company under the FCA's Disclosure and Transparency Rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRSFSSWMFASEIW
Date   Source Headline
18th Nov 20147:00 amRNSAppointment of a Non-Executive Director
5th Nov 20147:00 amRNSGrant of Options
4th Nov 20147:00 amRNSAppointment of Head of Clinical Science
23rd Oct 20143:19 pmRNSAnnual Report and Accounts
8th Oct 20147:44 amRNSDirectorate Change
1st Oct 201412:30 pmRNSTotal Voting Rights
30th Sep 20147:00 amRNSAmendment of 2012 Loan Note term
29th Sep 201410:52 amRNSHolding(s) in Company
24th Sep 20141:18 pmRNSExercise of Options
24th Sep 201412:12 pmRNSAnnual Report and Accounts
22nd Sep 20147:00 amRNSFinal Results
4th Sep 20147:00 amRNSShareholder update
24th Jul 20147:00 amRNSNotice of Results and Trading Update
17th Jul 20143:10 pmRNSHolding(s) in Company
30th Apr 20147:01 amRNSWorthing Facility Licence Renewal
25th Apr 20147:00 amRNSDirector/PDMR Shareholding
17th Apr 20147:00 amRNSExtension of Convertible Loan Note
24th Mar 20147:00 amRNSHalf Yearly Report
17th Mar 20147:00 amRNSNotice of Results
12th Mar 20147:00 amRNSShareholder update
19th Feb 20147:00 amRNSHealth Canada approves submission of CTA
27th Jan 20147:00 amRNSResults published in highly respected journal
14th Jan 20147:00 amRNSTrading Update and Notice of Results
20th Nov 20131:19 pmRNSResult of AGM
20th Nov 20137:00 amRNSBusiness and R&D Update
16th Oct 20134:21 pmRNSAnnual Report and Accounts
9th Oct 20138:48 amRNSNotification under AIM Rule Schedule Two (g)
27th Sep 20138:33 amRNSChange of Adviser
19th Sep 20133:51 pmRNSHolding(s) in Company
16th Sep 20137:00 amRNSFinal Results
3rd Jun 201310:23 amRNSHolding(s) in Company
15th May 201310:20 amRNSGrant of Options
8th May 201310:39 amRNSHolding(s) in Company
8th May 201310:18 amRNSHolding(s) in Company
25th Mar 20137:00 amRNSHalf Yearly Report
11th Mar 20137:00 amRNSUS patent granted
11th Mar 20137:00 amRNSNotice of results and shareholder update
22nd Jan 201310:41 amRNSExercise of Options
28th Dec 20127:00 amRNSTotal Voting Rights
27th Dec 201212:02 pmRNSUpdate on Lincoln Medical Final
19th Dec 20123:14 pmRNSGrant of Options
10th Dec 201211:44 amRNSDirector/PDMR Shareholding
5th Dec 20123:42 pmRNSTotal Voting Rights
4th Dec 201212:40 pmRNSExercise of Options
30th Nov 20129:00 amRNSTotal Voting Rights
21st Nov 20122:23 pmRNSHolding(s) in Company
20th Nov 20122:25 pmRNSExercise of Options
14th Nov 201211:41 amRNSResult of AGM
9th Nov 201212:12 pmRNSDirector/PDMR Shareholding
16th Oct 20123:54 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.